Page last updated: 2024-08-22

yttrium and Neoplasms

yttrium has been researched along with Neoplasms in 76 studies

Research

Studies (76)

Timeframe	Studies, this research(%)	All Research%
pre-1990	40 (52.63)	18.7374
1990's	0 (0.00)	18.2507
2000's	5 (6.58)	29.6817
2010's	24 (31.58)	24.3611
2020's	7 (9.21)	2.80

Authors

Authors	Studies
Engstová, H; Horák, D; Ježek, P; Macková, H; Oleksa, V; Patsula, V; Shapoval, O; Velychkivska, N	1
Jie, X; Wei, W; Wu, M; Yang, H	1
Lan, Y; Liu, J; Tang, M; Wu, Y; Zhang, J; Zhang, Y; Zhu, X	1
He, Y; Ju, H; Li, Y; Liu, Y; Zhang, X; Zhang, Y	1
Cheng, Q; Cheng, X; He, M; Huang, L; Jing, S; Li, L; Li, X; Liu, K; Wang, J; Wang, R; Wang, Y; Xu, H; Xu, J; Zhou, J; Zhu, X	1
Cao, J; Cheng, X; Du, L; Huang, P; Li, Q; Liu, Y; Sun, J; Zhang, C; Zhou, H	1
Guo, Z; Jiang, H; Li, J; Ming, J; Shi, C; Zhang, D; Zhang, X; Zhuang, R	1
Dong, J; Du, X; Huang, X; Yan, H	1
El-Toni, AM; Hu, L; Li, Q; Li, X; Lu, L; Wang, C; Wang, P; Wang, W; Zhang, F; Zhao, M	1
Hamblin, MR	1
Arellano, DL; Chauhan, K; Fournier, PGJ; Hirata, GA; Jain, A; Juárez, P; Sengar, P; Verdugo-Meza, A	1
Chen, C; Gong, H; Xu, R; Yee, LK; Zhang, Y	1
Gu, Z; Hu, Z; Jin, S; Liu, X; Ren, W; Tian, G; Yan, L; Yin, W; Zhang, X; Zhao, Y; Zhou, L	1
Dong, LX; Kong, D; Tang, SH; Wang, J; Yan, XP; Yang, CX	1
Gu, Z; Hu, Z; Ruan, L; Yang, Y; Yin, W; Zhang, X; Zhao, Y; Zheng, X; Zhou, L	1
He, D; Liu, Q; Na, N; Ouyang, J; Yang, C; Zhao, Y	1
Aalders, MC; Buma, WJ; Ding, Y; Holz, JA; Kong, X; Lambrechts, SA; Liu, K; Liu, X; Liu, Y; Nadort, A; Priem, B; Tu, L; Zhang, H; Zhang, Y	1
Chen, Y; Hou, Z; Huang, S; Li, C; Lin, J; Liu, B; Ma, P; Zhang, Y	1
Chen, ZF; Jiang, YH; Khan, TM; Li, ZQ; Liang, H; Liu, YC; Qin, JL; Shen, WY; Wang, M; Wei, JH	1
Koch, B; Mishra, K; Prasad, R; Rai, M; Rai, SB; Singh, AK; Singh, SK	1
Babu, PD; Barick, KC; Hassan, PA; Ningthoujam, RS; Pandey, BN; Sharma, A; Shetake, NG; Vatsa, RK	1
Cheng, Z; Deng, K; Deng, X; Hou, Z; Jin, D; Li, C; Lian, H; Lin, J	1
Ge, K; Jia, G; Jin, Y; Li, Z; Liang, XJ; Liu, H; Sun, W; Zhang, C; Zhang, J	1
Fisher, DR; Lin, Y; Wang, J; Wang, Z; Wu, H	1
Czernin, J; Hildebrandt, IJ; McCoy, MR; Meares, C; Olafsen, T; Phelps, ME; Radu, C; Weber, WA; Wei, LH; Wu, AM	1
Asok, A; Koyakutty, M; Menon, D; Nair, S; Setua, S	1
Guo, H; Idris, NM; Qian, H; Zhang, Y	1
Di, Y; Gao, H; Mao, C; Mi, C; Wang, M; Wu, X; Wu, Y; Xu, S; Xu, Z; Zhang, J	1
Christie, JK; Malik, J; Tilocca, A	1
Cao, C; Mao, C; Mi, C; Tian, Z; Wang, Z; Xu, S	1
Chen, Q; Wei, Y; Wu, B; Xing, D; Zhou, A	1
Bahadur, D; Kulkarni, H; Pradhan, L; Shanta Singh, N	1
Jadhav, N; Juluri, RR; Ningthoujam, RS; Pandey, BN; Parchur, AK; Prasad, AI; Vatsa, RK	1
Araki, N; Hiraoka, M; Inoue, Y; Kawashita, M; Kim, HM; Kokubo, T; Nagata, Y; Sawada, Y; Shineha, R	1
Chelli, M; Chinol, M; De Luca, A; Ginanneschi, M; Leone, G; Paganelli, G; Papi, S; Papini, AM; Sabatino, G	1
GREENBERG, J; HART, HE; LASZLO, D; LEWIN, R; SPENCER, H; STERN, KG	1
BROTHERS, M; HART, HE; LASZLO, D; SIEGEL, EP; SPENCER, H	1
EDELSTYN, GA; GLEADHILL, CA; LYONS, AR; RODGERS, HW; TAYLOR, AR; WELBOURN, RB	1
DOGLIOTTI, AM; RUFFO, A	1
CAMANNI, F; MASSARA, F; MOLINATTI, GM; OLIVETTI, M; PIZZINI, A; TEDESCHI, M	1
CHAMBERS, JS	1
FREY, E; MATTER, H; PESTALOZZI, D	1
FREY, E	1
GRADY, ED; NICOLSON, WP; ROLLINS, LC; SALE, W	1
BERINZEI, M; POLANSKI, T; TOT, S; VALD, B; ZOLTAN, L	1
FISHER, M; JONES, JC; WALTER, J	1
WALTER, J	1
FENYES, I; ZOLTAN, L	1
JONES, JC	1
HAYEM, M; JURET, P	1
BLAIR, DW; BROWN, DA; CARTER, PT; FORREST, AP; HARRINGTON, RW; SANDISON, AT; STEWART, HJ; VALENTINE, JM	1
FORREST, AP	1
GROS, C; ROILGEN, A; VLAHOVITCH, B	1
FESANI, F; GOFFRINI, P; PERACCHIA, A	1
DAVIS, FB; DISHER, SC; GOLDIE, H; SMITH, CS	1
DE VOS, WN; IRONSIDE, WM; MOSELEY, RD	1
BECKMANN, R; BORN, W	1
GREENE, WM	1
MARKS, S; SULLIVAN, MF; THOMPSON, RC	1
ARIEL, IM; GALEY, D; RESNICK, MI	1
ASAKURA, H	1
FLAISLER, A; HAYEM, M; JURET, P	1
LEMMENS, HA	1
COENGRACHT, JM; DE LANGE, SA; FRENKEL, M; LANKESTER, J; PLAATS, GJ; TOUBER, JL; VAN DER WERF, AJ	1
COLON, J; DARGENT, M; DUTOU, L; HAOUR, P; MAYER, M; POMMATAU, E; POULAIN, S	1
WALKER, LA	1
GORSKI, C; PASZKO, Z; PRONASZKO, A	1
DIETZ, H; SEVIN, W	1
BENNETT, AM; BOESEN, E; SMITH, EJ	1
COLON, J; DARGENT, M; DUTOUT, L	2
GRADY, ED; NOLAN, TR	1
Lubberink, M; Lundqvist, H; Tolmachev, V	1
Myers, DE; Vallera, DA	1
Stein, BS	1
Mitchener, M; Schroeder, HA	1

Reviews

2 review(s) available for yttrium and Neoplasms

Article	Year
RADIOACTIVE YTTRIUM 90: A REVIEW OF ITS PROPERTIES, BIOLOGICAL BEHAVIOR, AND CLINICAL USES. Acta radiologica: therapy, physics, biology, 1964, Volume: 2 Topics: Chelating Agents; Kidney Function Tests; Liver Function Tests; Neoplasms; Peritoneal Neoplasms; Radioactivity; Urinary Bladder Neoplasms; Yttrium; Yttrium Isotopes	1964
Immunotoxins containing ricin. Cancer treatment and research, 1988, Volume: 37 Topics: Ammonium Chloride; Antibodies, Monoclonal; Cross-Linking Reagents; Cyclophosphamide; Drug Evaluation; Drug Synergism; Galactose; Humans; Immunotoxins; Leukemia; Melanoma; Neoplasms; Receptors, Mitogen; Ricin; Yttrium	1988

Other Studies

74 other study(ies) available for yttrium and Neoplasms

Article	Year
Poly(N,N-dimethylacrylamide)-coated upconverting NaYF Scientific reports, 2021, 11-01, Volume: 11, Issue:1 Topics: Acrylamides; Fluorescent Dyes; Fluorides; HeLa Cells; Hep G2 Cells; Humans; Nanoparticles; Neoplasms; Optical Imaging; Yttrium	2021
Red-Near-Infrared Fluorescent Probe for Time-Resolved in Vivo Alkaline Phosphatase Detection with the Assistance of a Photoresponsive Nanocontainer. Analytical chemistry, 2019, 10-15, Volume: 91, Issue:20 Topics: Acetaminophen; Alkaline Phosphatase; Animals; Benzopyrans; Cell Line, Tumor; Chemical and Drug Induced Liver Injury; Female; Fluorescent Dyes; Humans; Metal Nanoparticles; Mice, Inbred BALB C; Neoplasms; Optical Imaging; Thulium; Ytterbium; Yttrium	2019
Construction of a near-infrared responsive upconversion nanoplatform against hypoxic tumors via NO-enhanced photodynamic therapy. Nanoscale, 2020, Apr-14, Volume: 12, Issue:14 Topics: Animals; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Curcumin; Fluorides; HeLa Cells; Humans; Infrared Rays; Metal Nanoparticles; Mice; Mice, Inbred BALB C; Neoplasms; Nitric Oxide; Oleic Acid; Photochemotherapy; Photosensitizing Agents; Porosity; Silicon Dioxide; Yttrium	2020
Activatable Photodynamic Therapy with Therapeutic Effect Prediction Based on a Self-correction Upconversion Nanoprobe. ACS applied materials & interfaces, 2020, Apr-29, Volume: 12, Issue:17 Topics: Animals; Antineoplastic Agents; Carbocyanines; Cathepsin B; Fluorescent Dyes; Fluorides; HeLa Cells; Humans; Lanthanoid Series Elements; Light; Metal Nanoparticles; Mice; Neoplasms; NIH 3T3 Cells; Photochemotherapy; Photosensitizing Agents; Reactive Oxygen Species; Rose Bengal; Xenograft Model Antitumor Assays; Yttrium	2020
Ferrocene Functionalized Upconversion Nanoparticle Nanosystem with Efficient Near-Infrared-Light-Promoted Fenton-Like Reaction for Tumor Growth Suppression. Inorganic chemistry, 2020, Jul-06, Volume: 59, Issue:13 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Carriers; Female; Ferrous Compounds; Humans; Infrared Rays; Liposomes; Metal Nanoparticles; Metallocenes; Mice, Inbred BALB C; Neoplasms; Terbium; Xenograft Model Antitumor Assays; Yttrium	2020
A Janus upconverting nanoplatform with biodegradability for glutathione depletion, near-infrared light induced photodynamic therapy and accelerated excretion. Journal of materials chemistry. B, 2020, 10-21, Volume: 8, Issue:40 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chlorophyllides; Erbium; Female; Fluorides; Glutathione; Humans; Infrared Rays; Mice, Inbred BALB C; Nanocomposites; Nanoparticles; Neoplasms; Photochemotherapy; Photosensitizing Agents; Porphyrins; Silicon Dioxide; Singlet Oxygen; Ytterbium; Yttrium	2020
Versatile fluorinated Pd@Au nanoplates doped with yttrium for tumor theranostics. Biomaterials science, 2021, May-04, Volume: 9, Issue:9 Topics: Cell Line, Tumor; Humans; Neoplasms; Photochemotherapy; Precision Medicine; Theranostic Nanomedicine; Yttrium	2021
Protein-Gated Upconversion Nanoparticle-Embedded Mesoporous Silica Nanovehicles via Diselenide Linkages for Drug Release Tracking in Real Time and Tumor Chemotherapy. ACS applied materials & interfaces, 2021, Jun-23, Volume: 13, Issue:24 Topics: Animals; Antineoplastic Agents; Cattle; Doxorubicin; Drug Carriers; Drug Liberation; Erbium; Female; Fluorides; Glutathione; HeLa Cells; Humans; Hydrogen Peroxide; Hydrogen-Ion Concentration; Metal Nanoparticles; Mice, Inbred C57BL; Myoglobin; Neoplasms; Porosity; Serum Albumin, Bovine; Silicon Dioxide; Xenograft Model Antitumor Assays; Ytterbium; Yttrium	2021
Kinetics-mediate fabrication of multi-model bioimaging lanthanide nanoplates with controllable surface roughness for blood brain barrier transportation. Biomaterials, 2017, Volume: 141 Topics: Animals; Blood-Brain Barrier; Capillary Permeability; Cell Line; Female; Fluorides; Kinetics; Lanthanoid Series Elements; Luminescent Measurements; Magnetic Resonance Imaging; Mice, Inbred BALB C; Nanostructures; Neodymium; Neoplasms; Optical Imaging; Permeability; Surface Properties; Ytterbium; Yttrium	2017
Upconversion in photodynamic therapy: plumbing the depths. Dalton transactions (Cambridge, England : 2003), 2018, Jul-14, Volume: 47, Issue:26 Topics: Animals; Cell Line, Tumor; Erbium; Fluorescence Resonance Energy Transfer; Fluorides; Humans; Infrared Rays; Light; Mice; Nanoparticles; Neoplasms; Oxygen; Photochemotherapy; Photons; Photosensitizing Agents; Reactive Oxygen Species; Thulium; Xenograft Model Antitumor Assays; Ytterbium; Yttrium	2018
Development of a functionalized UV-emitting nanocomposite for the treatment of cancer using indirect photodynamic therapy. Journal of nanobiotechnology, 2018, Feb-27, Volume: 16, Issue:1 Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Female; Folic Acid; Luminescent Agents; Male; Mice; Nanocomposites; Nanoparticles; Neoplasms; Photochemotherapy; Photosensitizing Agents; Prostatic Neoplasms; Protoporphyrins; Reactive Oxygen Species; Silicon Dioxide; Yttrium	2018
A facile synthesis of strong near infrared fluorescent layered double hydroxide nanovehicles with an anticancer drug for tumor optical imaging and therapy. Nanoscale, 2013, May-21, Volume: 5, Issue:10 Topics: Antimetabolites, Antineoplastic; Cell Line, Tumor; Cell Membrane; Drug Carriers; Erbium; Fluorescence; Fluorouracil; Humans; Hydroxides; Nanoparticles; Neoplasms; Tomography, Optical; Ytterbium; Yttrium	2013
A new near infrared photosensitizing nanoplatform containing blue-emitting up-conversion nanoparticles and hypocrellin A for photodynamic therapy of cancer cells. Nanoscale, 2013, Dec-07, Volume: 5, Issue:23 Topics: Cell Line, Tumor; Cell Survival; Contrast Media; Fluorides; Gadolinium; HeLa Cells; Humans; Infrared Rays; Magnetic Resonance Imaging; Metal Nanoparticles; Neoplasms; Perylene; Phenol; Photochemotherapy; Photosensitizing Agents; Polysorbates; Quinones; Radiography; Singlet Oxygen; Yttrium	2013
Ultrasonic assisted preparation of lanthanide-oleate complexes for the synthesis of multifunctional monodisperse upconversion nanoparticles for multimodal imaging. Nanoscale, 2014, Jul-21, Volume: 6, Issue:14 Topics: Animals; Cell Line, Tumor; Cell Survival; Coordination Complexes; Fluorides; Gadolinium; Humans; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasms; Oleic Acid; Sonication; Tomography, X-Ray Computed; Transplantation, Heterologous; Yttrium	2014
Mesoporous NaYbF4@NaGdF4 core-shell up-conversion nanoparticles for targeted drug delivery and multimodal imaging. Biomaterials, 2014, Volume: 35, Issue:26 Topics: Animals; Antineoplastic Agents; Cell Line; Cell Line, Tumor; Contrast Media; Doxorubicin; Drug Delivery Systems; Female; Fluorides; Folic Acid; Gadolinium; Humans; Luminescent Agents; Magnetic Resonance Imaging; Mice; Models, Molecular; Multimodal Imaging; Nanoparticles; Neoplasms; Tomography, X-Ray Computed; Yttrium	2014
Dual-modal imaging and photodynamic therapy using upconversion nanoparticles for tumor cells. The Analyst, 2014, Dec-21, Volume: 139, Issue:24 Topics: Contrast Media; Fluorides; Gadolinium; HEK293 Cells; HeLa Cells; Humans; Magnetic Resonance Imaging; Microscopy, Confocal; Nanoparticles; Neoplasms; Perylene; Phenol; Photochemotherapy; Photosensitizing Agents; Quinones; Silicon Dioxide; Yttrium	2014
Targeted labeling of an early-stage tumor spheroid in a chorioallantoic membrane model with upconversion nanoparticles. Nanoscale, 2015, Feb-07, Volume: 7, Issue:5 Topics: 3T3 Cells; Animals; Antibodies, Monoclonal; Cell Survival; Chick Embryo; Chickens; Chorioallantoic Membrane; Fluorides; Humans; MCF-7 Cells; Mice; Microscopy, Confocal; Models, Biological; Nanoparticles; Neoplasm Staging; Neoplasms; Yttrium	2015
Multifunctional NaYF4:Yb, Er@mSiO2@Fe3O4-PEG nanoparticles for UCL/MR bioimaging and magnetically targeted drug delivery. Nanoscale, 2015, Feb-07, Volume: 7, Issue:5 Topics: Animals; Antibiotics, Antineoplastic; Biocompatible Materials; Cell Survival; Contrast Media; Doxorubicin; Drug Carriers; Erbium; Female; Ferrosoferric Oxide; Fluorides; HeLa Cells; Humans; Magnetic Resonance Imaging; Magnetics; Mice; Nanoparticles; Neoplasms; Polyethylene Glycols; Silicon Dioxide; Tissue Distribution; Ytterbium; Yttrium	2015
Water-soluble oxoglaucine-Y(III), Dy(III) complexes: in vitro and in vivo anticancer activities by triggering DNA damage, leading to S phase arrest and apoptosis. Dalton transactions (Cambridge, England : 2003), 2015, Jul-07, Volume: 44, Issue:25 Topics: Animals; Antineoplastic Agents; Apomorphine; Apoptosis; Cell Cycle Checkpoints; Cell Line; Cell Line, Tumor; Cell Survival; Coordination Complexes; DNA; DNA Damage; Dysprosium; Humans; Medicine, Chinese Traditional; Mice; Neoplasms; Proto-Oncogene Proteins c-bcl-2; S Phase; Solubility; Topoisomerase Inhibitors; Tumor Burden; Water; X-Ray Diffraction; Yttrium	2015
Enhanced red upconversion emission, magnetoluminescent behavior, and bioimaging application of NaSc0.75Er0.02Yb0.18Gd0.05F4@AuNPs nanoparticles. ACS applied materials & interfaces, 2015, Jul-22, Volume: 7, Issue:28 Topics: Cell Line, Tumor; Gadolinium; Gold; HeLa Cells; Humans; Luminescence; Molecular Imaging; Nanoparticles; Neoplasms; Particle Size; Ytterbium; Yttrium	2015
Covalent bridging of surface functionalized Fe3O4 and YPO4:Eu nanostructures for simultaneous imaging and therapy. Dalton transactions (Cambridge, England : 2003), 2015, Sep-07, Volume: 44, Issue:33 Topics: Cell Line, Tumor; Europium; Ferrosoferric Oxide; Humans; Hyperthermia, Induced; Luminescent Agents; Magnetic Fields; Magnetics; Magnetite Nanoparticles; Nanostructures; Neoplasms; Optical Imaging; Phosphates; Yttrium	2015
808 nm Light-triggered and hyaluronic acid-targeted dual-photosensitizers nanoplatform by fully utilizing Nd(3+)-sensitized upconversion emission with enhanced anti-tumor efficacy. Biomaterials, 2016, Volume: 101 Topics: Animals; Apoptosis; Drug Delivery Systems; Female; Fluorides; HeLa Cells; Humans; Hyaluronic Acid; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neodymium; Neoplasms; Perylene; Phenol; Photochemotherapy; Photosensitizing Agents; Quinones; Reactive Oxygen Species; Titanium; Ultraviolet Rays; Yttrium	2016
Up-Conversion Y2O3:Yb(3+),Er(3+) Hollow Spherical Drug Carrier with Improved Degradability for Cancer Treatment. ACS applied materials & interfaces, 2016, Sep-28, Volume: 8, Issue:38 Topics: Animals; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Liberation; Erbium; Luminescence; Neoplasms; Yttrium	2016
Apoferritin-templated yttrium phosphate nanoparticle conjugates for radioimmunotherapy of cancers. Journal of nanoscience and nanotechnology, 2008, Volume: 8, Issue:5 Topics: Apoferritins; Humans; Metal Nanoparticles; Microscopy, Electron, Transmission; Neoplasms; Radioimmunotherapy; Yttrium	2008
Engineered antibody fragments with infinite affinity as reporter genes for PET imaging. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2008, Volume: 49, Issue:11 Topics: Animals; Antibodies, Monoclonal; Antibody Affinity; Base Sequence; Cell Line, Tumor; Feasibility Studies; Gene Expression Regulation, Neoplastic; Genes, Reporter; Heterocyclic Compounds, 1-Ring; Humans; Immunoglobulin Fragments; Mice; Neoplasms; Positron-Emission Tomography; Protein Engineering; Substrate Specificity; Tissue Distribution; Yttrium	2008
Folate receptor targeted, rare-earth oxide nanocrystals for bi-modal fluorescence and magnetic imaging of cancer cells. Biomaterials, 2010, Volume: 31, Issue:4 Topics: Carrier Proteins; Cell Line; Cell Line, Tumor; Cell Survival; Flow Cytometry; Folate Receptors, GPI-Anchored; Humans; Magnetic Resonance Imaging; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Molecular Imaging; Nanoparticles; Neoplasms; Quantum Dots; Reactive Oxygen Species; Receptors, Cell Surface; Spectroscopy, Fourier Transform Infrared; Yttrium	2010
Singlet oxygen-induced apoptosis of cancer cells using upconversion fluorescent nanoparticles as a carrier of photosensitizer. Nanomedicine : nanotechnology, biology, and medicine, 2010, Volume: 6, Issue:3 Topics: Apoptosis; Cell Line, Tumor; Cell Nucleus; Cell Nucleus Shape; Cell Survival; Cytochromes c; DNA Fragmentation; Drug Carriers; Fluorides; Humans; Indoles; Intracellular Space; Isoindoles; Male; Nanomedicine; Nanoparticles; Neoplasms; Organometallic Compounds; Oxidative Stress; Photochemotherapy; Photosensitizing Agents; Porosity; Prostate-Specific Antigen; Silicon Dioxide; Singlet Oxygen; Spectrometry, Fluorescence; Yttrium; Zinc Compounds	2010
Multifunctional nanocomposites of superparamagnetic (Fe3O4) and NIR-responsive rare earth-doped up-conversion fluorescent (NaYF4 : Yb,Er) nanoparticles and their applications in biolabeling and fluorescent imaging of cancer cells. Nanoscale, 2010, Volume: 2, Issue:7 Topics: Erbium; Ferrosoferric Oxide; Fluorescent Dyes; Fluorides; HeLa Cells; Humans; Magnetics; Metal Nanoparticles; Metals, Rare Earth; Microscopy, Fluorescence; Neoplasms; Spectrophotometry, Infrared; Ytterbium; Yttrium	2010
Bioactive glasses as potential radioisotope vectors for in situ cancer therapy: investigating the structural effects of yttrium. Physical chemistry chemical physics : PCCP, 2011, Oct-21, Volume: 13, Issue:39 Topics: Drug Delivery Systems; Glass; Molecular Dynamics Simulation; Molecular Structure; Neoplasms; Radioisotopes; Radionuclide Imaging; Yttrium	2011
Novel microwave-assisted solvothermal synthesis of NaYF4:Yb,Er upconversion nanoparticles and their application in cancer cell imaging. Langmuir : the ACS journal of surfaces and colloids, 2011, Dec-06, Volume: 27, Issue:23 Topics: Erbium; Fluorides; HeLa Cells; Humans; Microwaves; Nanoparticles; Neoplasms; Particle Size; Surface Properties; Temperature; Ytterbium; Yttrium	2011
High-sensitivity in vivo imaging for tumors using a spectral up-conversion nanoparticle NaYF4: Yb3+, Er3+ in cooperation with a microtubulin inhibitor. Nanoscale, 2012, Jul-07, Volume: 4, Issue:13 Topics: Animals; Diagnostic Imaging; Erbium; Fluorescent Dyes; Fluorides; Folic Acid; Human Umbilical Vein Endothelial Cells; Humans; Mice; Mice, Nude; Microtubules; Nanoparticles; Neoplasms; Signal-To-Noise Ratio; Stilbenes; Tubulin Modulators; Ytterbium; Yttrium	2012
A multifunctional biphasic suspension of mesoporous silica encapsulated with YVO4:Eu3+ and Fe3O4 nanoparticles: synergistic effect towards cancer therapy and imaging. Nanotechnology, 2013, Feb-15, Volume: 24, Issue:6 Topics: Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Carriers; Europium; Ferrosoferric Oxide; Humans; Hyperthermia, Induced; Magnetics; Nanoparticles; Neoplasms; Silicon Dioxide; Vanadates; Yttrium	2013
Bi-functional properties of Fe3O4@YPO4:Eu hybrid nanoparticles: hyperthermia application. Dalton transactions (Cambridge, England : 2003), 2013, Apr-14, Volume: 42, Issue:14 Topics: Animals; Cell Line; Europium; Ferrosoferric Oxide; Hyperthermia, Induced; Magnetite Nanoparticles; Mice; Neoplasms; Particle Size; Quantum Theory; Yttrium	2013
Preparation of ceramic microspheres for in situ radiotherapy of deep-seated cancer. Biomaterials, 2003, Volume: 24, Issue:17 Topics: Brachytherapy; Ceramics; Coated Materials, Biocompatible; Humans; Injections; Materials Testing; Microspheres; Neoplasms; Particle Size; Radiopharmaceuticals; Yttrium; Yttrium Radioisotopes	2003
A new biotin derivative-DOTA conjugate as a candidate for pretargeted diagnosis and therapy of tumors. Journal of medicinal chemistry, 2003, Jul-03, Volume: 46, Issue:14 Topics: Antineoplastic Agents; Avidin; Biotin; Chelating Agents; Drug Stability; Heterocyclic Compounds, 1-Ring; Humans; Isotope Labeling; Neoplasms; Protein Binding; Radiopharmaceuticals; Yttrium	2003
Biological studies on stable and radioactive rare earth compounds. III. Distribution of radioactive yttrium in normal and ascites-tumor-bearing mice, and in cancer patients with serous effusions. Journal of the National Cancer Institute, 1954, Volume: 15, Issue:1 Topics: Animals; Ascites; Humans; Mice; Neoplasms; Yttrium	1954
Radioyttrium (Y90) for the palliative treatment of effusions due to malignancy. Journal of the American Medical Association, 1956, Jun-09, Volume: 161, Issue:6 Topics: Exudates and Transudates; Humans; Neoplasms; Palliative Care; Radioactivity; Yttrium; Yttrium Radioisotopes	1956
Hypophysectomy combined with intrasellar irradiation with yttrium-90. Lancet (London, England), 1958, Mar-01, Volume: 1, Issue:7018 Topics: Breast; Breast Neoplasms; Humans; Hypophysectomy; Mastectomy; Neoplasms; Yttrium; Yttrium Radioisotopes	1958
[Interstitial irradiation of the pituitary gland with yttrium 90; indications, technic and results]. Minerva medica, 1958, Jun-16, Volume: 49, Issue:48 Topics: Humans; Neoplasms; Pituitary Gland; Yttrium; Yttrium Radioisotopes	1958
[Biochemical and hormonal changes in humans after intrasellar insertion of yttrium 90]. Minerva chirurgica, 1958, Oct-31, Volume: 13, Issue:20 Topics: Adrenal Cortex; Gonadotropins; Gonadotropins, Pituitary; Humans; Neoplasms; Phosphorus; Pituitary Gland; Sella Turcica; Thyroid Gland; Yttrium; Yttrium Radioisotopes	1958
A case of metastasizing chorionepithelioma treated by local excision and pituitary ablation with yttrium 90. The Journal of obstetrics and gynaecology of the British Commonwealth, 1961, Volume: 68 Topics: Choriocarcinoma; Female; Humans; Medical Records; Neoplasms; Pituitary Gland; Pregnancy; Radioactivity; Vaginal Neoplasms; Yttrium; Yttrium Radioisotopes	1961
[Transnasal implantation of a predominantly suprasellar hypophysial tumor with yttrium 90 rods]. Strahlentherapie, 1961, Volume: 114 Topics: Humans; Neoplasms; Pituitary Gland; Pituitary Neoplasms; Radioactivity; Skull; Yttrium; Yttrium Radioisotopes	1961
[Indications, technic and limitations of the transnasal implantation of radioisotopes in a pituitary tumor]. Radiologia clinica, 1960, Volume: 29 Topics: Humans; Neoplasms; Pituitary Gland; Pituitary Neoplasms; Radioactivity; Radioisotopes; Yttrium; Yttrium Radioisotopes	1960
Intra-arterial radioisotopes to treat cancer. The American surgeon, 1960, Volume: 26 Topics: Humans; Neoplasms; Neoplasms, Experimental; Radioisotopes; Yttrium; Yttrium Radioisotopes	1960
[Therapy of generalized forms of malignant tumors by the method of administration of Y90 into the hypophysis]. Voprosy onkologii, 1960, Volume: 6(10) Topics: Humans; Neoplasms; Pituitary Gland; Yttrium; Yttrium Radioisotopes	1960
Radioactive colloidal yttrium silicate in the treatment of malignant effusions. I. Clinical aspects and investigations. The British journal of radiology, 1961, Volume: 34 Topics: Humans; Neoplasms; Radioactivity; Silicates; Yttrium; Yttrium Radioisotopes	1961
Malignant effusions treated by colloidal radioactive yttrium silicate. British medical journal, 1960, Oct-29, Volume: 2, Issue:5208 Topics: Exudates and Transudates; Humans; Neoplasms; Pleural Effusion, Malignant; Silicates; Yttrium; Yttrium Radioisotopes	1960
Stereotactic diagnosis and radioactive treatment in a case of spheno-occipital chordoma. Journal of neurosurgery, 1960, Volume: 17 Topics: Brain Neoplasms; Chordoma; Humans; Neoplasms; Occipital Lobe; Supratentorial Neoplasms; Yttrium; Yttrium Radioisotopes	1960
Radioactive colloidal yttrium silicate in the treatment of malignant effusions. II. Calculations of tissue dosage. The British journal of radiology, 1961, Volume: 34 Topics: Humans; Neoplasms; Radioactivity; Silicates; Yttrium; Yttrium Radioisotopes	1961
[Implantation of intrapituitary radioactive material (Au-198 and Y-90) in metastatic cancers of the breast. Clinical and biological review apropos of 75 cases]. Revue francaise d'etudes cliniques et biologiques, 1961, Volume: 6 Topics: Breast; Breast Neoplasms; Gold Radioisotopes; Humans; Hypophysectomy; Neoplasms; Neoplasms, Second Primary; Yttrium; Yttrium Radioisotopes	1961
Radio-active implantation of the pituitary. The British journal of surgery, 1959, Volume: 47 Topics: Humans; Neoplasms; Pituitary Gland; Yttrium; Yttrium Radioisotopes	1959
Treatment of advanced breast cancer by yttrium-90 implantation of the pituitary. Acta - Unio Internationalis Contra Cancrum, 1959, Volume: 15 Topics: Breast; Breast Neoplasms; Humans; Neoplasms; Pituitary Diseases; Yttrium; Yttrium Radioisotopes	1959
[Hypophysectomy for cancer. Surgical method. Stereotaxic method. Comparative study of 28 cases]. Annales de chirurgie, 1960, Volume: 14 Topics: Hypophysectomy; Neoplasms; Radioactivity; Stereotaxic Techniques; Yttrium; Yttrium Radioisotopes	1960
[Implantation of radioactive yttrium (Y90) in the sella turcica in the treatment of breast and prostate carcinoma in the advanced stage (considerations on 21 cases)]. Archivio italiano di chirurgia, 1959, Volume: 85 Topics: Breast; Breast Neoplasms; Humans; Hypophysectomy; Male; Neoplasms; Prostatic Neoplasms; Sella Turcica; Yttrium; Yttrium Radioisotopes	1959
Prevention of peritoneal free (ascites) tumor cell growth and implantation by pretreatment with radioactive yttrium. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1959, Volume: 102 Topics: Animals; Ascites; Cell Proliferation; Humans; Neoplasms; Neoplasms, Experimental; Peritoneum; Yttrium; Yttrium Radioisotopes	1959
Yttrium implantation of the hypophysis by the nasal route. Acta - Unio Internationalis Contra Cancrum, 1959, Volume: 15 Topics: Humans; Neoplasms; Pituitary Gland; Yttrium; Yttrium Radioisotopes	1959
[The current radiotherapy of hemangioma on the basis of the premature infant as an example]. Munchener medizinische Wochenschrift (1950), 1962, Aug-24, Volume: 104 Topics: Child; Hemangioma; Humans; Infant; Infant, Newborn; Infant, Premature; Neoplasms; Radioactivity; Strontium; Strontium Radioisotopes; Yttrium; Yttrium Radioisotopes	1962
EMBOLIZATION OF DOG PROSTATES WITH YTTRIUM-90 MICROSPHERES. The Journal of urology, 1963, Volume: 90 Topics: Dogs; Embolism; Embolization, Therapeutic; Humans; Male; Microspheres; Neoplasms; Prostatic Neoplasms; Radiation Protection; Research; Yttrium; Yttrium Radioisotopes	1963
BETA IRRADIATION OF RAT INTESTINE. LONG-TERM STUDIES AFTER DAILY YTTRIUM-90 INGESTION. The American journal of pathology, 1963, Volume: 43 Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Cornea; Female; Intestinal Neoplasms; Intestines; Leiomyosarcoma; Mouth Neoplasms; Neoplasms; Neoplasms, Experimental; Neoplasms, Radiation-Induced; Radiation Injuries, Experimental; Rats; Research; Ulcer; Uterine Neoplasms; Yttrium; Yttrium Isotopes	1963
THE INTRALYMPHATIC ADMINISTRATION OF RADIOACTIVE ISOTOPES AND CANCER CHEMOTHERAPEUTIC DRUGS. Surgery, 1964, Volume: 55 Topics: Abdominal Neoplasms; Angiography; Breast Neoplasms; Geriatrics; Gold; Humans; Injections; Iodine Isotopes; Leukemia; Lymphatic Metastasis; Lymphatic System; Lymphography; Lymphoma; Lymphoma, Non-Hodgkin; Melanoma; Melphalan; Methotrexate; Neoplasms; Radioisotopes; Radionuclide Imaging; Retroperitoneal Neoplasms; Scandium; Thiotepa; Yttrium	1964
[INTRATUMORAL INJECTION THERAPY WITH YTTRIUM-90 CHLORIDE COLLOID]. Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica, 1964, Volume: 23 Topics: Animals; Biomedical Research; Bone Marrow; Breast Neoplasms; Colloids; Humans; Injections; Injections, Intralesional; Kidney; Liver; Mastectomy; Mice; Necrosis; Neoplasm Metastasis; Neoplasms; Radiotherapy Dosage; Research; Sarcoma; Sarcoma, Experimental; Skin Neoplasms; Spleen; Yttrium; Yttrium Isotopes	1964
[APROPOS OF 150 IMPLANTATIONS OF INTRA-HYPOPHYSIAL RADIOACTIVE YTTRIUM IN THE TREATMENT OF ADVANCED BREAST CANCER. TECHNIC; CLINICAL RESULTS; INDICATIONS]. Journal de chirurgie, 1964, Volume: 87 Topics: Breast; Breast Neoplasms; Humans; Neoplasm Metastasis; Neoplasms; Pituitary Gland; Pituitary Irradiation; Postoperative Complications; Radiography; Yttrium; Yttrium Isotopes	1964
[DESTRUCTION OF THE HYPOPHYSIS BY IMPLANTATION OF YTTRIUM-90 IN METASTASIZING BREAST CANCER AND OTHER DISORDERS]. Nederlands tijdschrift voor geneeskunde, 1963, Jul-06, Volume: 107 Topics: Breast Neoplasms; Exophthalmos; Humans; Neoplasm Metastasis; Neoplasms; Pituitary Gland; Pituitary Irradiation; Pituitary Neoplasms; Yttrium; Yttrium Isotopes	1963
[DISCUSSIONS ON MAMMARY CANCER. 6. STATE OF PATIENTS WITH METASTATIC MAMMARY CANCER AFTER TREATMENT BY HYPOPHYSECTOMY WITH RADIOACTIVE YTTRIUM]. Jaarboek van kankeronderzoek en kankerbestrijding in Nederland. Yearbook for cancer research and fight against cancer in the Netherlands, 1963, Volume: 13 Topics: Breast; Breast Neoplasms; Humans; Hypophysectomy; Neoplasm Metastasis; Neoplasms; Pituitary Irradiation; Radioactivity; Yttrium; Yttrium Isotopes	1963
[COMPARATIVE VALUE OF ADRENAL SURGERY AND HYPOPHYSIOLYSIS WITH YTTRIUM 90 IN THE TREATMENT OF ADVANCED BREAST CANCER IN WOMEN]. Acta chirurgica Belgica, 1964, Volume: 63 Topics: Adrenal Gland Neoplasms; Adrenalectomy; Breast Neoplasms; Castration; Female; Geriatrics; Humans; Liver Neoplasms; Neoplasm Metastasis; Neoplasms; Ovary; Pituitary Irradiation; Splenectomy; Yttrium; Yttrium Isotopes	1964
[GONADOTROPIC FUNCTION TESTS OF THE PITUITARY IN CANCER WITH BREAST CANCER TREATED BY THE INTRAHYPOPHYSEAL ADMINISTRATION OF YTTRIUM 90]. Nowotwory, 1964, Volume: 14 Topics: Breast Neoplasms; Gonadotropins; Gonadotropins, Pituitary; Humans; Neoplasms; Pituitary Diseases; Pituitary Gland; Pituitary Irradiation; Yttrium; Yttrium Isotopes	1964
[RESULTS OF RADIOTHERAPY OF SKIN DISEASES WITH STRONTIUM 90-YTTRIUM 90]. Archiv fur klinische und experimentelle Dermatologie, 1964, Jun-25, Volume: 219 Topics: Humans; Neoplasms; Radiotherapy; Skin Diseases; Skin Neoplasms; Strontium; Strontium Isotopes; Yttrium; Yttrium Isotopes	1964
PITUITARY DESTRUCTION BY THE IMPLANTATION OF YTTRIUM 90 RODS INTO THE PITUITARY FOSSA FROM ABOVE UNDER STEREOTAXIC RADIOGRAPHIC CONTROL. Acta - Unio Internationalis Contra Cancrum, 1964, Volume: 20 Topics: Breast Neoplasms; Cerebrospinal Fluid Rhinorrhea; Humans; Meningitis; Neoplasm Metastasis; Neoplasms; Pituitary Irradiation; Postoperative Complications; Sella Turcica; Stereotaxic Techniques; Yttrium; Yttrium Isotopes	1964
[HYPOPHYSECTOMY WITH RADIOACTIVE YTTRIUM IN THE TREATMENT OF BREAST CANCER IN ADVANCED STAGES]. Lyon chirurgical, 1964, Volume: 60 Topics: Breast Neoplasms; Humans; Hypophysectomy; Neoplasms; Pituitary Irradiation; Radioactivity; Yttrium; Yttrium Isotopes	1964
[HYPOPHYSIOLYSIS WITH RADIOACTIVE YTTRIUM IN THE TREATMENT OF ADVANCED BREAST CANCER]. Lyon chirurgical, 1965, Volume: 61 Topics: Breast; Breast Neoplasms; Humans; Neoplasms; Pituitary Irradiation; Radioactivity; Yttrium; Yttrium Isotopes	1965
[INTRA-ARTERIAL APPLICATION OF LARGE PARTICLES OF YTTRIUM 90 FOR TREATMENT OF TUMORS]. Minerva medica, 1965, Jun-09, Volume: 56 Topics: Humans; Injections, Intra-Arterial; Neoplasms; Yttrium; Yttrium Isotopes	1965
Production, PET performance and dosimetric considerations of 134Ce/134La, an Auger electron and positron-emitting generator for radionuclide therapy. Physics in medicine and biology, 2002, Feb-21, Volume: 47, Issue:4 Topics: Cesium Radioisotopes; Electrons; Humans; Isotopes; Kinetics; Lanthanum; Neoplasms; Radiometry; Scattering, Radiation; Tomography, Emission-Computed; Yttrium; Yttrium Radioisotopes	2002
Laser physics and tissue interaction. The Urologic clinics of North America, 1986, Volume: 13, Issue:3 Topics: Animals; Argon; Carbon Dioxide; Dogs; Hematoporphyrin Photoradiation; Hot Temperature; Humans; Laser Therapy; Lasers; Liver; Neoplasms; Quantum Theory; Urinary Bladder; Yttrium	1986
Scandium, chromium(VI), gallium, yttrium, rhodium, palladium, indium in mice: effects on growth and life span. The Journal of nutrition, 1971, Volume: 101, Issue:10 Topics: Aging; Animals; Body Weight; Carcinogens; Chromium; Female; Gallium; Growth; Indium; Longevity; Male; Mice; Neoplasms; Palladium; Rats; Rhodium; Scandium; Sex Factors; Tooth; Weaning; Yttrium	1971